Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nutrition 21 Chromax Claims Should Reflect “Real World” Performance – NAD

This article was originally published in The Tan Sheet

Executive Summary

Nutrition 21 should modify performance claims for its newly launched Chromax chromium picolinate product to "more closely mirror the results and limitations in the applicable studies," according to the National Advertising Division

You may also be interested in...



Nutrition 21 Expands Into Cardiovascular Area With Iceland Health Buy

Nutrition 21 strengthens its focus on finished products and gains entry to the omega-3 market with the purchase of fish oil importer and manufacturer Iceland Health

Chromium Picolinate “Insulin Resistance” Qualified Health Claim Clears FDA

FDA approved Nutrition 21's chromium picolinate qualified health claim for reduced risk of insulin resistance that can lead to type 2 diabetes, the firm stated Aug. 29

Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”

Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement

Topics

UsernamePublicRestriction

Register

PS099765

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel